BTBD9-FARS2 Fusion FISH Probe
The BTBD9-FARS2 Fusion FISH Probe is used to confirm a fusion of the BTBD9 and FARS2 genes. The fusion of the BTBD9 and FARS2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BTBD9-FARS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-FARS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
FARS2 Gene Summary
This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Gene Name: Phenylalanyl-tRNA Synthetase 2, Mitochondrial
Chromosome: CHR6: 5261583 -5771816
Locus: 6p25.1
BTBD9 Gene Summary
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
Gene Name: BTB Domain Containing 9
Chromosome: CHR6: 38136226 -38607924
Locus: 6p21.2
Gene Diseases
The BTBD9 FARS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|